126 related articles for article (PubMed ID: 20504097)
1. Effects of early initiated oestrogen replacement therapy on plasma homocysteine levels in women in surgically induced menopause.
Yüksel H; Cobanoğlu M; Odabaşi AR; Sezer SD; Küçük M; Serter M
Gynecol Endocrinol; 2011 Feb; 27(2):101-6. PubMed ID: 20504097
[TBL] [Abstract][Full Text] [Related]
2. Effect of non-oral estrogen on risk markers for metabolic syndrome in early surgically menopausal women.
Kilic S; Yilmaz N; Erdogan G; Aydin M; Tasdemir N; Doganay M; Batioglu S
Climacteric; 2010 Feb; 13(1):55-62. PubMed ID: 19591007
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the effects of sequential transdermal versus continuous orally administered hormone replacement therapies on plasma total homocysteine levels in postmenopausal women: a randomized, placebo-controlled study.
Kurtay G; Ozmen B
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):206-11. PubMed ID: 16814449
[TBL] [Abstract][Full Text] [Related]
4. Oestrogen replacement after oophorectomy: comparison of patches and implants.
Anderson CH; Raju SK; Forsling ML; Wheeler MJ
BMJ; 1992 Jul; 305(6845):90-1. PubMed ID: 1449552
[No Abstract] [Full Text] [Related]
5. Effects of estrogen replacement therapy on estrogen receptor expression and immunoregulatory cytokine secretion in surgically induced menopausal women.
Xia X; Zhang S; Yu Y; Zhao N; Liu R; Liu K; Chen X
J Reprod Immunol; 2009 Jul; 81(1):89-96. PubMed ID: 19497624
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
[TBL] [Abstract][Full Text] [Related]
7. [Transdermal administration of estrogens in women with the postcastration and climacteric syndromes].
Rotta L; Matĕchová E
Cesk Gynekol; 1992 Sep; 57(7):336-40. PubMed ID: 1394497
[TBL] [Abstract][Full Text] [Related]
8. Therapy with climara in surgical menopause.
Bădoi D; Crauciuc E; Rusu L; Luca V
Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):828-33. PubMed ID: 23272537
[TBL] [Abstract][Full Text] [Related]
9. [Changes of plasminogen activator inhibitor (PAI-1) during estrogen replacement therapy].
Zizka Z; Fait T; Vrablík M
Cas Lek Cesk; 2007; 146(11):874-7. PubMed ID: 18069215
[TBL] [Abstract][Full Text] [Related]
10. [Systen--transdermal estradiol for substitution following surgical menopause].
Rachev E; Karag'ozov I
Akush Ginekol (Sofiia); 1995; 34(3):74-6. PubMed ID: 8743861
[TBL] [Abstract][Full Text] [Related]
11. Menopause rather than estrogen modifies plasma homocysteine levels.
Marchesoni D; Driul L; Plaino L; Villani MT; Becagli L; Mozzanega B
Int J Gynaecol Obstet; 2003 Jun; 81(3):293-7. PubMed ID: 12767572
[TBL] [Abstract][Full Text] [Related]
12. Effect of oral or transdermal hormone replacement therapy on homocysteine levels: a randomized clinical trial.
Bruschi F; Dal Pino D; Fiore V; Parazzini F; Di Pace R; Cesana BM; Melotti D; Crosignani PG
Maturitas; 2004 May; 48(1):33-8. PubMed ID: 15223106
[TBL] [Abstract][Full Text] [Related]
13. Do different delivery systems of estrogen therapy influence serum lipids differently in surgically menopausal women?
Baksu B; Davas I; Agar E; Akyol A; Uluocak A
J Obstet Gynaecol Res; 2007 Jun; 33(3):346-52. PubMed ID: 17578365
[TBL] [Abstract][Full Text] [Related]
14. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
[TBL] [Abstract][Full Text] [Related]
16. The effect of estradiol valerate and dienogest combination on serum homocysteine levels in postmenopausal women: a clinical trial.
Pirimoglu ZM; Aygun E; Dansuk R; Kucukercan I; Unal O; Turan C
Gynecol Endocrinol; 2005 Sep; 21(3):185-8. PubMed ID: 16335913
[TBL] [Abstract][Full Text] [Related]
17. Effect of transdermal estrogen therapy on some vasoactive humoral factors and 24-h ambulatory blood pressure in normotensive postmenopausal women.
Zacharieva S; Atanassova I; Kirilov G; Kalinov K; Shigarminova R; Nachev E; Aslanova N
Climacteric; 2002 Sep; 5(3):293-9. PubMed ID: 12419088
[TBL] [Abstract][Full Text] [Related]
18. Hormonal therapy in the patient with surgical menopause.
Weinstein L
Obstet Gynecol; 1990 Apr; 75(4 Suppl):47S-50S; discussion 51S-52S. PubMed ID: 2179790
[TBL] [Abstract][Full Text] [Related]
19. [Changes in C-reactive protein levels induced by different application forms of estrogen replacement therapy].
Fait T; Vrablík M; Kostírová M; Trnková B
Cas Lek Cesk; 2006; 145(7):571-4; discussion 574. PubMed ID: 16921788
[TBL] [Abstract][Full Text] [Related]
20. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
